The DEA Just Scheduled a New Synthetic Opioid Your Fentanyl Test Strip Can't See

On July 1, the DEA quietly did something it has done twenty times before: it placed a newly identified synthetic opioid — cychlorphine, along with three related compounds — into Schedule I, the DEA’s most restrictive category, on an emergency basis. What makes this one different from the last twenty isn’t the scheduling. It’s the chemistry.

A fentanyl test strip is only as good as its ability to recognize fentanyl, and cychlorphine was built from a different starting material specifically so that it wouldn’t.

Every novel synthetic opioid that’s shown up in the drug supply over the past several years — nitazenes, nitazene analogs, most of the fentalogues — has shared a close enough chemical resemblance to fentanyl that the test strips harm reduction programs hand out by the thousands can usually flag them. Cychlorphine breaks that pattern. According to UNODC’s early-warning notice, which first tracked the compound through a Paris drug-checking service before it turned up in U.S. and U.K. toxicology reports, cychlorphine is synthesized from an entirely different chemical family than fentanyl or the nitazenes — roughly ten times as potent in preclinical pharmacology, and not reliably caught by routine fentanyl immunoassay strips or opioid urine screens. UNODC and DEA toxicology together have tied it to roughly 78 postmortem cases across the two countries so far.

This is the fourth wave of a pattern that’s now familiar to anyone who’s watched the drug supply since 2020: medetomidine, a veterinary sedative unrelated to opioids entirely, showed up in fentanyl-adulterated supply and caused a withdrawal syndrome naloxone doesn’t reverse; nitazenes showed up next, chemically close enough to fentanyl that test strips mostly still work; now cychlorphine arrives explicitly outside that detection net. Scheduling the compound stops legal manufacture and signals prosecutors can charge it. It does nothing for the person holding a strip that was never built to see it.

If you or someone you’re supporting relies on fentanyl test strips as a safety check, the honest update is this: a negative result no longer means what it used to. It still tells you fentanyl isn’t present. It has never told you nothing dangerous is, and as of July 1, that gap has a name.